This last semester ended with good news for KitoZyme: a new product launch to treat constipation – TransiBiota® - and the presentation of medical results on its last innovation combining weight and digestive actions - FiberSlim™ - on CPHI Frankfurt.



KitoZyme is already well-known for its expertise in the Weight Management. But 2016 was the year of the innovation with the launch of a new products range in Digestive Health.

After having experimented success with these products, KitoZyme launches TransiBiota®, a new medical device for:

·        treatment of moderate constipation,

·        promotion of normal transit, and

·        relief of gastro-intestinal symptoms related to constipation and/or gut dysbiosis.

TransiBiota® is available in a convenient delivery form: 1 to 2 sachet(s)/day with orange flavour.


In parallel, KitoZyme presents the results of its user test of FiberSlim™ with 22 patients under medical control.

FiberSlim™ is a medical device that reduces caloric intake, restores a healthy gut microflora and reduces oxidative stress.

We were able to show

·        A quick effect on digestive symptoms

·        A feeling of digestive well-being thanks to improved transit and a feeling of "deflation".

·        A rapid and progressive weight loss from the beginning: 2.3kg in 4 weeks.


All these products are composed of our unique, 100% natural and patented ingredient: KiOtransine® and other ingredients to create the best combinations. These four products constitute the new range in Digestive Health and permit to KitoZyme to grow up its expertise field.


Visit us on booth 91F49 at CPHI Frankfurt

To have more information on these products or our other products in Weight Management, feel free to contact us or visit us our booth 91F49 Hall 9.1 at CPHI Frankfurt